n(g),n(g')-dimethyl-l-arginine has been researched along with Angiogenesis, Pathologic in 9 studies
N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine
| Excerpt | Relevance | Reference |
|---|---|---|
| "The endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine (ADMA) is increased in patients with coronary artery disease and may regulate function of circulating angiogenic progenitor cells (APCs) by small regulatory RNAs." | 7.76 | Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism. ( Bauersachs, J; Ertl, G; Fiedler, J; Fleissner, F; Galuppo, P; Gupta, SK; Jazbutyte, V; Kneitz, S; Mayr, M; Thum, T; Xu, Q; Yin, X, 2010) |
| "The endogenous nitric oxide synthase inhibitor asymmetrical dimethylarginine (ADMA) is increased in patients with coronary artery disease and may regulate function of circulating angiogenic progenitor cells (APCs) by small regulatory RNAs." | 3.76 | Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism. ( Bauersachs, J; Ertl, G; Fiedler, J; Fleissner, F; Galuppo, P; Gupta, SK; Jazbutyte, V; Kneitz, S; Mayr, M; Thum, T; Xu, Q; Yin, X, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buijs, N | 1 |
| Oosterink, JE | 1 |
| Jessup, M | 1 |
| Schierbeek, H | 1 |
| Stolz, DB | 1 |
| Houdijk, AP | 1 |
| Geller, DA | 1 |
| van Leeuwen, PA | 1 |
| Reddy, KRK | 1 |
| Dasari, C | 2 |
| Duscharla, D | 1 |
| Supriya, B | 2 |
| Ram, NS | 1 |
| Surekha, MV | 1 |
| Kumar, JM | 2 |
| Ummanni, R | 2 |
| Wieczór, AM | 1 |
| Wieczór, R | 1 |
| Kulwas, A | 1 |
| Rość, D | 1 |
| Kami Reddy, KR | 1 |
| Vandavasi, S | 1 |
| Natani, S | 1 |
| Jadav, SS | 1 |
| Sai Ram, N | 1 |
| Fleissner, F | 1 |
| Jazbutyte, V | 1 |
| Fiedler, J | 1 |
| Gupta, SK | 1 |
| Yin, X | 1 |
| Xu, Q | 1 |
| Galuppo, P | 1 |
| Kneitz, S | 1 |
| Mayr, M | 1 |
| Ertl, G | 1 |
| Bauersachs, J | 1 |
| Thum, T | 1 |
| Schlager, O | 1 |
| Giurgea, A | 1 |
| Schuhfried, O | 1 |
| Seidinger, D | 1 |
| Hammer, A | 1 |
| Gröger, M | 1 |
| Fialka-Moser, V | 1 |
| Gschwandtner, M | 1 |
| Koppensteiner, R | 1 |
| Steiner, S | 1 |
| Boult, JK | 1 |
| Walker-Samuel, S | 1 |
| Jamin, Y | 1 |
| Leiper, JM | 1 |
| Whitley, GS | 1 |
| Robinson, SP | 1 |
| Singh, JP | 1 |
| Wipff, J | 1 |
| Avouac, J | 1 |
| Borderie, D | 1 |
| Zerkak, D | 1 |
| Lemarechal, H | 1 |
| Kahan, A | 1 |
| Boileau, C | 1 |
| Allanore, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)[NCT03883412] | Phase 4 | 60 participants (Anticipated) | Interventional | 2019-02-28 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for n(g),n(g')-dimethyl-l-arginine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Asymmetric dimethylarginine and angiogenesis: biological significance.
Topics: Animals; Arginine; Atherosclerosis; Cardiovascular Diseases; Endothelial Cells; Humans; Neovasculari | 2018 |
Dimethylarginine dimethylaminohydrolase: a new therapeutic target for the modulation of nitric oxide and angiogenesis.
Topics: Amidohydrolases; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Arginine; Endotheli | 2007 |
1 trial available for n(g),n(g')-dimethyl-l-arginine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: a randomized controlled trial.
Topics: Aged; Arginine; Cell Movement; Chemokine CXCL12; Endothelial Cells; Exercise; Female; Flow Cytometry | 2011 |
6 other studies available for n(g),n(g')-dimethyl-l-arginine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.
Topics: Aged; Amidohydrolases; Arginine; Carcinoma, Hepatocellular; Cell Hypoxia; Female; Hep G2 Cells; Huma | 2017 |
Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
Topics: Amidohydrolases; Animals; Arginine; Cell Movement; Cell Proliferation; Fibroblast Growth Factor 2; G | 2018 |
Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.
Topics: Amidohydrolases; Animals; Antineoplastic Agents; Arginine; Cell Line, Tumor; Cell Proliferation; Cel | 2019 |
Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism.
Topics: Angiogenesis Inhibitors; Arginine; Coronary Artery Disease; Gene Expression Regulation; Humans; Micr | 2010 |
Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas.
Topics: Amidohydrolases; Animals; Arginine; Catalytic Domain; Female; Glioma; Magnetic Resonance Imaging; Mi | 2011 |
Disturbed angiogenesis in systemic sclerosis: high levels of soluble endoglin.
Topics: Adult; Aged; Antigens, CD; Arginine; Biomarkers; Cross-Sectional Studies; Endoglin; Female; Humans; | 2008 |